Abiopharma

COURTOIS SA : Variation droits de vote 07/2026

NYSE Content Update: Pinnacle Acquisition + Ticketplus to Debut for Trade

Other Report or Announcement

Other Report or Announcement

General Announcement: THE PROPOSED ENTRY INTO A WAREHOUSING AND LOGISTICS COOPERATION AS AN INTERESTED PERSON TRANSACTION

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Clinical trial NCT07291232 updates: 1. completion date: 2026-10-01 → 2027-03-01 2. primary completion date: 2026-10-01 → 2027-03-01 3. enrollment: 48 → 80 participants

Clinical trial NCT04689828: completion date: 2026-09-30 → 2026-09-10.

Clinical trial NCT06932588 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2027-07-01 3. primary completion date: 2026-06-01 → 2026-07-09 4. enrollment: 350 → 351 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07519772: enrollment: 200 → 280 participants.